With the wide spread of the COVID-19 in the world, all activities related to health care have been affected and this includes transplantation surgeries (1). Considering the high transmission rate of the virus and limitations in resources such as intensive care unit (ICU) beds and blood products, in many countries living donor transplantations and pancreas transplantation have been delayed to after the diseases has subsided.